These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35533920)

  • 1. Orlistat disposition in the human jejunum and the effect of lipolysis inhibition on bile salt concentrations and composition.
    Braeckmans M; Brouwers J; Mols R; Servais C; Tack J; Augustijns P
    Int J Pharm; 2022 Jun; 621():121807. PubMed ID: 35533920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Fed State Lipolysis Inhibition on the Intraluminal Behaviour and Absorption of Fenofibrate from a Lipid-Based Formulation.
    Braeckmans M; Brouwers J; Riethorst D; Servais C; Tack J; Augustijns P
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate oral absorption from SNEDDS and super-SNEDDS is not significantly affected by lipase inhibition in rats.
    Michaelsen MH; Siqueira Jørgensen SD; Abdi IM; Wasan KM; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2019 Sep; 142():258-264. PubMed ID: 31276759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intrajejunal acidity on lipid digestion and aqueous solubilisation of bile acids and lipids in health, using a new simple method of lipase inactivation.
    Zentler-Munro PL; Fine DR; Fitzpatrick WJ; Northfield TC
    Gut; 1984 May; 25(5):491-9. PubMed ID: 6714793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs.
    Iwanaga K; Kushibiki T; Miyazaki M; Kakemi M
    Biol Pharm Bull; 2006 Mar; 29(3):508-12. PubMed ID: 16508155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human intestinal fluid layer separation: The effect on colloidal structures & solubility of lipophilic compounds.
    Riethorst D; Mitra A; Kesisoglou F; Xu W; Tack J; Brouwers J; Augustijns P
    Eur J Pharm Biopharm; 2018 Aug; 129():104-110. PubMed ID: 29802985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of bile salts and lipids on intestinal absorption of griseofulvin in man.
    Palma R; Vidon N; Houin G; Pfeiffer A; Rongier M; Barre J; Bernier JJ
    Eur J Clin Pharmacol; 1986; 31(3):319-25. PubMed ID: 3792429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs.
    Suys EJA; Brundel DHS; Chalmers DK; Pouton CW; Porter CJH
    J Control Release; 2021 Mar; 331():45-61. PubMed ID: 33450318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems.
    Tran T; Bønløkke P; Rodríguez-Rodríguez C; Nosrati Z; Esquinas PL; Borkar N; Plum J; Strindberg S; Karagiozov S; Rades T; Müllertz A; Saatchi K; Häfeli UO
    J Control Release; 2020 Jan; 317():375-384. PubMed ID: 31765705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
    Mohsin K
    AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile salts in digestion and transport of lipids.
    Macierzanka A; Torcello-Gómez A; Jungnickel C; Maldonado-Valderrama J
    Adv Colloid Interface Sci; 2019 Dec; 274():102045. PubMed ID: 31689682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: An in vitro evaluation for the treatment of obesity.
    Joyce P; Dening TJ; Meola TR; Gustafsson H; Kovalainen M; Prestidge CA
    Eur J Pharm Sci; 2019 Jul; 135():1-11. PubMed ID: 31067495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring galactolipid digestion and simultaneous changes in lipid-bile salt micellar organization by real-time NMR spectroscopy.
    Sahaka M; Bornet O; Marchand A; Lafont D; Gontero B; Carrière F; Launay H
    Chem Phys Lipids; 2024 Jan; 258():105361. PubMed ID: 37981224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
    Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
    J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kolliphor surfactants affect solubilization and bioavailability of fenofibrate. Studies of in vitro digestion and absorption in rats.
    Berthelsen R; Holm R; Jacobsen J; Kristensen J; Abrahamsson B; Müllertz A
    Mol Pharm; 2015 Apr; 12(4):1062-71. PubMed ID: 25679417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
    He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
    Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dynamic in vitro lipolysis model. II: Evaluation of the model.
    Zangenberg NH; Müllertz A; Kristensen HG; Hovgaard L
    Eur J Pharm Sci; 2001 Oct; 14(3):237-44. PubMed ID: 11576829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ileal transposition into the upper jejunum affects lipid and bile salt absorption in rats.
    Tsuchiya T; Kalogeris TJ; Tso P
    Am J Physiol; 1996 Oct; 271(4 Pt 1):G681-91. PubMed ID: 8897889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
    Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
    Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.